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Abstract. 
 
Mutational analyses of genes that encode 
components of the anchoring complex underlying the 
basolateral surface of external epithelia indicate that 
this structure is the major element providing for resis-
tance to external friction. Ultrastructurally, laminin 5 
(
 
a
 
3
 
b
 
3
 
g
 
2; a component of the anchoring filament) ap-
pears as a thin filament bridging the hemidesmosome 
with the anchoring fibrils. Laminin 5 binds the cell sur-
face through hemidesmosomal integrin 
 
a
 
6
 
b
 
4. How-
ever, the interaction of laminin 5 with the anchoring 
fibril (type VII collagen) has not been elucidated. In 
this study we demonstrate that monomeric laminin 5 
binds the NH
 
2
 
-terminal NC-1 domain of type VII col-
lagen. The binding is dependent upon the native con-
formation of both laminin 5 and type VII collagen NC-1. 
Laminin 6 (
 
a
 
3
 
b
 
1
 
g
 
1) has no detectable affinity for type 
VII collagen NC-1, indicating that the binding is medi-
ated by the 
 
b
 
3 and/or 
 
g
 
2 chains of laminin 5. Approxi-
mately half of the laminin 5 solubilized from human 
amnion or skin is covalently complexed with laminins 6 
or 7 (
 
a
 
3
 
b
 
2
 
g
 
1). The adduction occurs between the NH
 
2
 
 
terminus of laminin 5 and the branch point of the short 
arms of laminins 6 or 7. The results are consistent with 
the presumed orientation of laminin 5, having the 
COOH-terminal G domain apposed to the hemidesmo-
somal integrin, and the NH
 
2
 
-terminal domains within 
the lamina densa. The results also support a model pre-
dicting that monomeric laminin 5 constitutes the an-
choring filaments and bridges integrin 
 
a
 
6
 
b
 
4 with type 
VII collagen, and the laminin 5–6/7 complexes are 
present within the interhemidesmosomal spaces bound 
at least by integrin 
 
a
 
3
 
b
 
1 where they may mediate base-
ment membrane assembly or stability, but contribute 
less significantly to epithelial friction resistance.
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E
 
lectron
 
 microscopic evaluation of the epithelial–
stromal junction of many external tissues after
conventional fixation and dehydration protocols
shows a lamina densa and lamina lucida much like that
seen for other basement membranes. In addition, spaced
along the length of the basal lamina are structures termed
the adhesion complex (for reviews see Burgeson, 1993
 
a
 
,
 
b
 
;
Gerecke et al., 1994
 
a
 
). These complexes consist of elec-
tron dense thickenings of the basolateral plasma mem-
brane called hemidesmosomes, due to their resemblance
to half of the desmosomal plaques present on the plasma
membranes at sites of cell–cell contact. Cytoskeletal kera-
tin filaments insert into both the hemidesmosomes and the
desmosomes bridging all aspects of the cellular plasma
membranes within a given cell, and provide a continuous
intercellular network throughout the entire epidermis.
Thin filaments, termed “anchoring filaments,” span the
lamina lucida and insert into the lamina densa. At high
resolution, the anchoring filaments appear to be continu-
ous with centrosymmetrically banded structures, termed
“anchoring fibrils” (Ellison and Garrod, 1984). The an-
choring fibrils originate within the lamina densa and
project into the upper regions of the papillary dermis.
About 800 nm in length, the anchoring fibrils either loop
back to reinsert into the lamina densa, or insert into struc-
tures termed “anchoring plaques” (Keene et al., 1987) that
appear as junctions between two or more anchoring fibrils.
Additional anchoring fibrils originate in the plaques and
extend further into the papillary dermis. The resulting net-
work engulfs banded collagen fibers and other fibrous ele-
ments of the papillary dermis, thus assuring the strength of
the union of the basement membrane and the upper dermis.
The molecules contained in these structures have been
partly identified and characterized. Laminin 5 localizes to
the anchoring filaments (Rousselle et al., 1991); it contains
three unique subunits, 
 
a
 
3 (Ryan et al., 1994), 
 
b
 
3 (Gerecke
et al., 1994
 
b
 
), and 
 
g
 
2 (Kallunki et al., 1992). In skin and
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amnion, laminin 5 is proteolytically processed after secre-
tion (Marinkovich et al., 1992
 
a
 
). The 200-kD 
 
a
 
3 chain is
cleaved first to 165 kD, and finally to 145-kD. The 
 
g
 
2
chain is processed from 155 kD to 105 kD, while the 
 
b
 
3
chain remains intact. Thus, three forms of laminin 5 are
seen: an intracellular form (
 
a
 
3, 200 kD; 
 
b
 
3, 140 kD; 
 
g
 
2,
155 kD), and two tissue forms (
 
a
 
3, 165 kD; 
 
b
 
3, 140 kD; 
 
g
 
2,
105 kD) and (
 
a
 
3, 145 kD; 
 
b
 
3, 140 kD; 
 
g
 
2, 105 kD). The
 
g
 
2 chain cannot bind nidogen under physiological condi-
tions (Mayer et al., 1995), and therefore laminin 5 alone
cannot associate with perlecan or the collagen IV network
(Yurchenco et al., 1985). Laminin 5 also lacks the short
arm domains believed to be required to promote assembly
into laminin networks (Schittny and Yurchenco, 1990;
Yurchenco et al., 1992). Laminin can be incorporated into
the basement membrane through a unique mechanism in-
volving cross-linking of laminin 5 with laminin 6 (
 
a
 
3
 
b
 
1
 
g
 
1)
or laminin 7 (
 
a
 
3
 
b
 
2
 
g
 
1) (Champliaud et al., 1996).
Anchoring fibrils are disulfide bond–stabilized dimers of
type VII collagen (Morris et al., 1986; Sakai et al., 1986).
The biosynthetic product is a monomer containing a large
NH
 
2
 
-terminal globular domain (Parente et al., 1991), NC-1
(Lunstrum et al., 1986), an unusually long and interrupted
triple-helical domain (Bentz et al., 1983), and a relatively
small COOH-terminal globular domain, NC-2, that is pro-
teolytically removed during maturation of the anchoring
fibrils, and is probably involved in the dimerization pro-
cess (Morris et al., 1986; Lunstrum et al., 1987; Bruckner-
Tuderman et al., 1994). Immunoelectron microscopic stud-
ies of the location of well-characterized epitopes within
type VII collagen indicate that the NC-1 domain is con-
tained within the lamina densa (Keene et al., 1987). There-
fore, a model of the interactions that stabilize the epithe-
lial–stromal attachment has evolved that postulates epithelial
cell binding to the laminin 5–6/7 complex 
 
a
 
3 G domains,
binding of the laminin 5 complex to the collagen network
via nidogen, and binding of the type VII collagen NC-1 do-
main to the basement membrane through interactions of
NC-1 with type IV collagen (Burgeson et al., 1990).
Recently, the gene defects underlying Herlitz’s junc-
tional epidermolysis bullosa have been identified as muta-
tions in genes encoding laminin 5 chains that result in pre-
mature termination codons in both alleles. The resulting
laminin 5 null phenotype is characterized by extensive
blistering of the skin and the mucosal surfaces of the respi-
ratory and digestive tracts, leading to death during the
early months of life. The Herlitz phenotype can be due to
mutations in the genes encoding 
 
a
 
3 (Kivirikko et al.,
1995), 
 
b
 
3 (Pulkkinen et al., 1994
 
b
 
; Pulkkinen et al., 1995;
Vailly et al., 1995), or 
 
g
 
2 (Pulkkinen et al., 1994
 
a
 
). This
was surprising since the model predicted that laminin 6 or
7 could partially substitute for laminin 5 since it can bind
both epithelial cells (through the 
 
a
 
3 chains) and basement
membranes (through 
 
g
 
1-mediated interactions with ni-
dogen). Therefore, only 
 
a
 
3 mutations were predicted to
cause Herlitz’s junctional epidermolysis bullosa. These
findings indicate that additional and uncharacterized in-
teractions must be required for epithelial–stromal stabil-
ity. The ultrastructure of the anchoring complex (Ellison
and Garrod, 1984) suggests a direct interaction of the an-
choring filaments with the anchoring fibrils. Hence, we
evaluated the binding of type VII collagen to laminin 5.
 
Materials and Methods
 
Antibodies
 
Preparation and characterization of laminin 5 and 6 antibodies mAb
BM165 (anti-
 
a
 
3 chain), mAb SF12 (anti-
 
g
 
2), mAb 545 (anti-
 
b
 
1), and
polyclonal antibody (pAb)
 
1
 
 anti-laminin 5 have been described elsewhere
(Rousselle et al., 1991; Marinkovich et al., 1992
 
b
 
). mAb NP32 to the NC-I
domain of type VIl procollagen, and pAb made to the whole type VII pro-
collagen molecule have been previously described (Sakai et al., 1986; Lun-
strum et al., 1986). pAb anti-laminin 1 was purchased from Sigma Chimie
(St. Quentin Fallavier, France).
 
Cell Culture and Immunopurification of Type VII 
Procollagen, Laminin 5, and Laminin 6
 
WISH cells derived from human amnion (certified cell line [CCL] 25;
American Type Culture Collection, Rockville, MD) were grown in DME
(GIBCO BRL, Gaithersburg, MD) supplemented with 10% FCS, 2 mM
glutamine, 1 mM sodium pyruvate, 50 U/ml penicillin, 50 ng/ml streptomy-
cin. Squamous carcinoma cells (SCC) 25 (CCL 25; American Type Cul-
ture Collection) were grown in 50% Ham’s F-12 and 50% DME-F12
(GIBCO BRL), supplemented with 10% FCS 2 mM glutamine, hydrocor-
tisone (0.4 
 
m
 
g/ml), and the same cocktail of antibiotics. Normal human ke-
ratinocytes (NHK) were isolated from neonatal foreskin (Rousselle et al.,
1991) and grown in monolayer culture in synthetic serum-free medium
(keratinocyte-SFM; GIBCO BRL).
For type VII procollagen purification, proteins secreted from confluent
WISH monolayers were collected during a 24-h incubation in serum-free
medium containing 100 ng/ml ascorbic acid as previously described (Lun-
strum et al., 1986). For laminin 5 and laminin 6 purification, culture media
were regularly harvested from confluent SCC25 culture. In all cases, after
collection, unattached cells were removed by centrifugation (2,000 
 
g
 
/min),
and EDTA, 
 
N
 
-methylmaleimide, and phenylmethanesulfonyl fluoride
were added to final concentration of 5 mM, 50 mM, and 50 mM, respec-
tively. Spent culture media (500 ml) from WISH cells was passed sequen-
tially over 25 ml of gelatin–Sepharose (Pharmacia Fine Chemicals, Piscat-
away, NJ) and 2 ml of NP32–Sepharose (Pharmacia Fine Chemicals).
Spent culture media from SCC25 cells was passed sequentially over 25 ml
of gelatin-Sepharose, and then over 5 ml of 545–Sepharose (anti-laminin
 
b
 
1) for laminin 6 purification, and then over 10 ml of BM165–Sepharose
(anti-laminin 
 
a
 
3) for laminin 5 purification. Affinity chromatography on
gelatin Sepharose was necessary and sufficient to remove fibronectin from
the conditioned media as indicated by immunoblotting with a pAb against
fibronectin (not shown). The antigens were eluted with 1M acetic acid, im-
mediately neutralized, and fractions were monitored for absorbance at
280 nm. Pooled fractions were dialyzed against PBS and kept frozen at
 
2
 
20
 
8
 
C. Protein concentration was determined by microprotein assay using
bincinchoninic acid (Pierce Interchim, Montlucon Cedex, France).
 
Extraction of NC1 (Type VII Collagen) and Laminin
5–Laminin 6 Complex from Amniotic Membranes
 
Extraction and purification of NC-1 (type VII collagen) and laminin 5–lam-
inin 6 complex from collagenase extract of amniotic membrane have been
described previously (Bachinger et al., 1990; Marinkovich et al., 1992
 
b
 
).
Antibodies used during the affinity chromatography step include mAbs
NP32, 545, and 6F12. Bound material was eluted with 1 M acetic acid and
immediately neutralized. Eluted fractions were analyzed by electrophore-
sis, pooled, and dialyzed against PBS and kept at 
 
2
 
20
 
8
 
C.
 
Extraction of the Laminin 5–NC1 Complex from 
Amniotic Membranes
 
The type VII collagen–NC1 preparation immunopurified from collage-
nase extracts of amniotic membranes was dialyzed against PBS and passed
over an mAb 6F12 (anti-laminin 
 
b
 
3) affinity chromatography column.
Bound material was eluted with 1 M acetic acid, immediately neutralized,
and eluted fractions were ethanol precipitated and analyzed by Western
blotting with polyclonal anti-laminin 5 and with mAb NP-32 (anti-VII
NC1).
 
1.
 
 Abbreviations used in this paper
 
: NHK, normal human keratinocytes;
pAb, polyclonal antibody; SCC, squamous carcinoma cells. 
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Sources of Other Proteins
 
Collagens XII and XIV were extracted from bovine tendon (Aubert-
Foucher et al., 1992) and kindly donated by Dr. E. Aubert-Foucher (Insti-
tut de Biologie et Chimie des Proteines [IBCP], Lyon, France). Laminin
1–nidogen complex and collagen IV extracted from the Engelbreth-Holm-
Swarm tumor of the mouse were kindly provided by Dr. M. Aumailley
(IBCP), and purchased from Collaborative Biomedical Products (TEBU,
Perray en Yvelines, France), respectively. Bovine collagen I was a gener-
ous gift of Dr. F. Ruggiero (IBCP).
 
Collagenase and Pepsin Treatment of Type
VII Collagen
 
Incubations with bacterial collagenase (10 
 
m
 
g/ml; CLSPA; Worthington
Biochemical Co., Freehold, NJ) were for 8 h at 37
 
8
 
C in 50 mM Tris-HCl,
pH 7.5, 500 mM NaCl, and 5 mM CaCI
 
2
 
. Pepsin digestion (100 
 
m
 
g/ml) was
for 45 min at 4
 
8
 
C in 0.5 M acetic acid, 0.1 M NaCl. After enzymatic treat-
ments, samples were dialyzed against PBS before interaction studies.
 
Protein Binding and Cell Adhesion Assays
 
The assay used was based on proteins immobilized on a plastic surface
that were then exposed to varying concentrations of dissolved ligands fol-
lowed by an enzyme immunoassay detection system. Multiwell plates (96
wells; Greiner, Dutscher, France) were incubated with solutions of the
first ligand (10 
 
m
 
g/ml, 100 
 
m
 
l per well) dissolved in 20 mM Na
 
2
 
CO
 
3
 
, pH
9.2, for 18 h at 4
 
8
 
C. The wells were then blocked with 2% milk powder dis-
solved in 0.05 M Tris-HCl, pH 7.2, 0.2 M NaCl (TBS). All further steps
were carried out in 2% milk powder in TBS, 0.02% Tween 20, and washes
between steps were with TBS, 0.02% Tween 20. Wells were incubated
with soluble ligand (0.6–40 
 
m
 
g/ml) for 2 h at 22
 
8
 
C and exposed (1 h, 22
 
8
 
C)
to a constant amount of diluted pAb against the soluble ligand followed
by a typical enzyme–immunoassay reaction with peroxidase conjugate of
goat anti–rabbit immunoglobulin (DAKOPATTS, Copenhagen, Den-
mark) as second antibody and 2,2
 
9
 
-azino-bis(3-ethylbenthiazoline-6-sul-
fonic acid) as the chromogenic substrate. Color yields were determined at
405 nm in an ELISA reader (MR5000; Dynatech Labs., Ltd., Guernsey,
Channel Islands, UK). Negative control values, from wells in which the
soluble ligands were omitted, were subtracted from the binding data. For
inhibition assays, soluble ligands were incubated with inhibitors (0.2–60
 
m
 
g/ml) for 6 h at 4
 
8
 
C before being added to the immobilized ligand. For
experiments testing effects of cations, 1% BSA dissolved in TBS was used
instead of 2% milk powder.
Measurements of cell adhesion to test protein-coated 96-well plates
were performed using colorimetric detection assays as have been previ-
ously described (Aumailley et al., 1989). Adhesion of NHK to laminin 5
(0.5 
 
m
 
g/well) was prevented by preincubation of the substrate with various
concentrations of mAb BM165 (0–10 
 
m
 
g/ml) as previously described
(Rousselle and Aumailley, 1994).
 
Formation of the Laminin 5-NC1 (Type VII Collagen) 
Complex In Vitro and Immunoprecipitation
 
Preparations of purified laminin 5 (20 
 
m
 
g/ml), purified NC-1 type VII col-
lagen (10 
 
m
 
g/ml), a mixture of laminin 5 (20 
 
m
 
g/ml) and NC-1 (10 
 
m
 
g/ml),
and a mixture of laminin 5 (20 
 
m
 
g/ml) and thermal denatured NC-1 (10
 
m
 
g/ml) were obtained after dilution in PBS to a final volume of 300 
 
m
 
l. To
perform thermal denaturation of NC-1, the protein was heat denaturated
for 10 min at 80
 
8
 
C, immediately cooled and mixed with the laminin 5. All
the samples were incubated 16 h at 4
 
8
 
C under gentle agitation. Each sam-
ple was then incubated 1 h at room temperature with a specific immuno-
bead complex prepared as follows: 200 
 
m
 
l GammaBind G Sepharose
(Pharmacia Biotech S.A., St. Quentin Yvelines, France) were incubated
overnight with 2 
 
m
 
g of mAb BM165 specific to 
 
a
 
3 chain of laminin 5,
washed four times with PBS, and then incubated with each of the samples
described above. The beads were collected by centrifugation, washed five
times with PBS containing 0.05% Tween, and two times with PBS. The
beads were resuspended in SDS–lysis buffer and boiled for 3 min. The re-
leased materials were analyzed by SDS-PAGE and immunoblotting.
 
Rotary Shadowing
 
Solutions of single proteins and of protein complexes were diluted to 10
 
mg/ml with 0.2 M ammonium bicarbonate, and after addition of an equal
volume of glycerol, the solutions were sprayed onto freshly cleaved mica
sheets. The samples were immediately placed on the holder of a MED 010
evaporator (Balzers S.p.A., Milan, Italy) and rotary shadowing was car-
ried out as previously described (Ruggiero et al., 1993). Observations of
replicas were performed with a Philips CM120 microscope (Phillips Tech-
nologies, Cheshire, CT) at the Centre de Microscople Electronique Appli-
quée à la Biologie et à la Géologie, Université Claude Bernard, Lyon,
France).
Enbloc (Diffusion) Immunolabeling
Fresh neonatal foreskin was immunolabeled as previously described (Sa-
kai and Keene, 1994). Briefly, fresh tissue was rinsed in PBS and then sub-
mersed overnight in mAb BM-165 (anti-laminin a3) diluted 1:5 in PBS or
a mixture of BM-165 and rabbit pAb 3959 (anti-type VII collagen) at a ra-
tio of 1:1:4 parts PBS. After an extensive rinse in PBS, the tissue was sub-
mersed overnight in secondary antibodies conjugated to different size gold
particles (Amersham International, Little Chalfont, UK) as described in the
legend for Fig. 9. Silver enhancement was performed on samples labeled
with 1 nm gold. The samples were rinsed extensively in PBS and 0.1 M ca-
codylate buffer and then fixed, dehydrated, and embedded in Spurr’s ep-
oxy resin. 90-nm thick sections, which included the epithelium, papillary,
and reticular dermis, were stained in uranyl acetate and lead citrate and
examined using a Philips EM 410 transmission electron microscope.
Results
Laminin 5 was purifed from the culture medium of SCC25
cells. The preparation was homogeneous as judged by
SDS-PAGE (Fig. 1, lane 1), and contained the proteolyti-
cally processed a3 chain at 165 kD, the unprocessed b3
chain (140 kD), and unprocessed g2 chain (155 kD), which
Figure 1. Electrophoretic analysis of immunoaffinity-purified
laminin 5 from cell culture media and type VII collagen–NC-1
from collagenase extracts of amniotic membranes. 2 mg of materi-
als affinity purified on mAb 6/F12 from SCC25 cell culture me-
dium (lane 1), and 2 mg of materials affinity purified on mAb NP-
32 from collagenase extracts of amniotic membranes (lane 2)
were separated by SDS-PAGE after reduction on a 3–7.5% gra-
dient polyacrylamide gel and visualized by Coomassie blue stain-
ing. Consistent with previous results, the reduced bands repre-
senting subunits of laminin 5 (a3, 165 kD; b3, 140 kD; g2, 155 and
105 kD) and type VII collagen–NC-1 (150 kD). The electro-
phoretic migration position of purified NC-1 before disulfide-
bond reduction is shown in lane 3. Migration positions of the mo-
lecular weight markers are indicated to the left of each gel.The Journal of Cell Biology, Volume 138, 1997 722
fail to resolve on this gel, and the fully processed g2 chain
(105 kD). Solid phase protein binding assays were first op-
timized for signal strength and specificity using the docu-
mented affinity of collagen IV for the laminin 1–nidogen
complex (Aumailley et al., 1989; and data not shown). The
assay demonstrated saturable binding of collagen IV to
laminin–nidogen, four- to fivefold stronger than to col-
lagen I. Under these conditions, laminin 5, collagens XII
and XIV, and the NC-1 domain of collagen VII showed
minimal binding.
To test the potential binding of laminin 5 to type VII
collagen, type VII procollagen was partially purified from
WISH cell (spontaneously transformed amniotic epithelial
cell line) culture medium by immunoaffinity chromatogra-
phy using NP-32–Sepharose. Solutions of 0–20 mg/ml of
laminin 5 were incubated with multiwell plates precoated
with partially purified type VII procollagen, a clostridial
collagenase digest of the type VII procollagen prepara-
tion, a pepsin digest of the type VII procollagen prepara-
tion, and purified type VII collagen NC-1. Saturable bind-
ing of type VII procollagen to laminin 5 was observed (Fig.
2), indicating that the two molecules did interact either di-
rectly or indirectly. To localize the binding activity within
type VII procollagen to the triple-helical or nontriple-heli-
cal domains, the procollagen solution was digested sepa-
rately with pepsin or collagenase before coating multi-
chamber wells. Incubation with pepsin completely eliminated
binding of laminin 5, while removal of the triple helix aug-
mented the interaction. These observations suggest that
the laminin 5–type VII collagen interaction occurs through
either NC-1 or NC-2 of type VII procollagen. Since NC-2
is proteolytically removed during anchoring fibril forma-
tion (Lunstrum et al., 1987; Bruckner-Tuderman et al.,
1994), if the interaction has physiological relevance, it is
most likely an interaction of NC-1 with laminin 5. There-
fore, NC-1 was purified from human amnion using estab-
lished methods. The product was .95% pure as judged by
SDS-PAGE (Fig. 1, lane 2) and by rotary shadowing
(Bachinger et al., 1990) (not shown). The majority of the
purified NC-1 remained trimeric as shown by electro-
phoretic separation without disulfide bond reduction (Fig.
1, lane 3). NC-1 showed comparable binding to laminin 5
as was seen with collagenase-digested type VII procol-
lagen. The results show a direct interaction of laminin 5
with type VII collagen mediated by the large NC-1 do-
main. We believe that the difference in binding seen be-
tween pure NC-1 or collagenase-treated type VII procol-
lagen and intact type VII procollagen is not significant as it
most likely results from removal of collagenous contami-
nants (primarily type VI collagen aggregates) from the
procollagen preparation by collagenase digestion thereby
increasing the effective NC-1 concentration.
The specificity of this interaction was tested by evaluat-
ing the relative binding of type VII–NC-1, laminin 1–nido-
gen, and collagens I-, IV-, XII-, and XIV-coated wells to
soluble laminin 5. As illustrated in Fig. 3 A, only type VII–
NC-1 strongly bound laminin 5. The laminin 1–nidogen
complex showed background affinity for laminin 5. When
type VII–NC-1 was added in solution to laminin 5–coated
wells (Fig. 3 B), again NC-1 bound most strongly to lami-
nin 5. Under these conditions, NC-1 showed no affinity for
laminin 1–nidogen, but type VII–NC-1 did bind collagen
IV as previously shown (Burgeson et al., 1990), but only to
about half the extent of the binding to laminin 5. Of partic-
ular interest, laminin 6 showed little binding to type VII–
NC-1 relative to laminin 5 even though both laminins
share the same a3 subunit (Champliaud et al., 1996). Con-
sistent with this finding, NC-1 showed diminished binding
to laminin 5 when complexed with laminin 6. However,
the molar amounts of laminin 5 present in the complex so-
lutions are z50% the molar concentration of laminin 5 in
solutions of laminin 5 alone. Since laminin 6 does not bind
NC-1, the laminin 5–6 complex binds NC-1 with the same
efficiency or only slightly diminished efficiency relative to
laminin 5 alone. The binding of 5 mg of NC-1 to laminin 5
was inhibited by preincubation of NC-1 with increasing
concentrations of laminin 5, but not by preincubation with
laminin 1–nidogen (Fig. 4).
The dependence of binding upon the native conforma-
tion of either laminin 5 or NC-1 was tested by separately
heating each of the ligands to 858C for 10 min, and then
rapidly cooling them before the solid phase binding assay.
Figure 2. Binding of soluble
laminin 5 to immobilized
type VII procollagen. Micro-
titer wells were coated with 1
mg of type VII–NC-1 purified
from amnion (d) or intact
type VII procollagen immu-
nopurified from WISH cell
culture medium (h), or type
VII procollagen digested
with either bacterial collage-
nase (s) or pepsin (j). pAb
to laminin 5 were used for
detecting the amount of
bound substrate.
Figure 3. (A) Interaction of laminin 5 with various immobilized
extracellular matrix components Binding of soluble laminin 5 to
immobilized collagen I (h), collagen IV (j), collagen XII (m),
collagen XIV (n), NC-1-VII (d), and laminin 1–nidogen com-
plex (s) at a concentration of 1 mg per well was determined by a
pAb in an enzyme-coupled second antibody reaction as described
in Materials and Methods. (B) Interaction of type VII–NC-1 with
type IV collagen and with various laminin isoforms. Binding of
soluble type VII–NC-1 to immobilized collagen IV (j), laminin
1–nidogen complex (s), laminin 5 (d), laminin 6 (h), and lami-
nin 5–laminin 6 complex (m) at the concentration of 1 mg per well
was determined by a pAb in an enzyme-coupled second antibody
reaction as described in Materials and Methods.Rousselle et al. Laminin 5 Binds Collagen Type VII 723
The denaturation products were not degraded during the
heat treatment (data not shown). Denaturation of either
ligand completely abolished binding (data not shown).
The temperature at which the laminin 5 conformation nec-
essary for binding to NC-1 is lost was then examined. The
midpoint of the temperature where loss of active confor-
mation occurs was z658C (Fig. 5 A). mAb BM165 inhibits
the binding of epithelial cells to laminin 5 (Rousselle et al.,
1991). Therefore, the ability of BM165 to disrupt the bind-
ing of laminin 5 to NC-1 was evaluated. As shown in Fig. 5
B, BM165 very effectively inhibits cell binding, but has no
effect upon the laminin 5–NC-1 interaction. Divalent cat-
ions are also required for the binding of type VII collagen
and laminin 5, as the addition of 10 mM EDTA completely
inhibits the interaction (data not shown).
To be certain that the binding of laminin 5 to type VII
collagen NC-1 was not artifactually influenced by the
solid-phase conditions, purified laminin 5 was coincubated
in solution with and without NC-1, and with heat-dena-
tured NC-1, and then complexed and uncomplexed laminin
5 was isolated by immunoprecipitation using anti-laminin
a3 (BM-165). The immunoprecipitation products were
separated by SDS-PAGE after disulfide bond reduction.
Laminin 5 and NC-1 were identified by Western blot anal-
ysis using polyclonal anti-laminin 5 and monoclonal anti-
NC-1 (NP32). Immunoprecipitated laminin 5 in the absence
of NC-1 gave the expected pattern by Western analysis
(Fig. 6, lane A1) and did not react with anti-NC-1 (Fig. 6,
lane B1). Immunoprecipitation of NC-1 in the absence of
laminin 5 produced no product (Fig. 6, lanes A2 and B2).
Both laminin 5 (Fig. 6, lane A3) and NC-1 (Fig. 6, lane B3)
were immunoprecipitated from the mixture of the two,
while denatured NC-1 did not precipitate with laminin 5
(Fig. 6, lanes A4 and B4). The results obtained using these
conditions confirm the solid-phase binding data and again
emphasize the importance of the native conformation of
NC-1.
Images of NC-1–laminin 5 adduct produced in solution
as described above were examined by transmission elec-
tron microscopy after rotary shadowing. Three types of
images were seen (Fig. 7). One was identical to the images
previously reported for laminin 5 (Rousselle et al., 1991).
The second image appeared as a somewhat irregular
spheroid, with its shortest diameter being z41 nm (41 6 9
nm; n 5 53). Occasionally spheroids with contiguous sin-
gle rod-like structures resembling collagen triple helices
were seen. We interpret these structures to be trimeric
NC-1 with some partial digestion products, consistent with
the electrophoretic band pattern (Fig. 1). The third image
seen appears as complexes of the first two forms. The im-
ages are consistent with visualization of the NC-1 and
laminin 5 monomers, and of the complex of one laminin 5
molecule with each NC-1 fragment.
If laminin 5 and type VII collagen NC-1 interact in vivo,
it may be possible to solubilize the complex if the tissue is
solubilized under nondenaturing conditions. NC-1 was
prepared as a collagenase digest of amnion and partially
purified by NP32 (anti-NC-1) immunoaffinity chromatog-
raphy. If a complex exists in this mixture, it should be re-
tained by 6F12 (anti-laminin b3) immunoaffinity columns.
Thus, partially purified NC-1 eluted from the anti-NC-1
column was applied to a column containing anti-b3. The
flow-through (Fig. 8, lanes 2 and 6, nonbound) is Western
Figure 4. Inhibition of type
VII–NC-1 binding to immo-
bilized laminin 5 by preincu-
bation with various competi-
tors. The test system
consisted of laminin 5 as the
immobilized phase at the
concentration of 1 mg per
well, and a fixed amount of
soluble type VII collagen–
NC-1 (5 mg/ml). Type VII–
NC1 was incubated at 48C for
8 h with varying concentra-
tion of laminin 5 (d) or lami-
nin 1–nidogen complex (s)
before testing on the insolu-
ble ligand.
Figure 5. (A) Effect of heat denaturation on laminin 5 interac-
tion with type VII–NC-1. Multiwell plates were coated with lami-
nin 5 (d) at concentration of 1 mg before or after heating at the
indicated temperatures. Soluble type VII–NC-1 was then added
at concentration of 10 mg/ml and bound material was determined
by a pAb in an enzyme-coupled second antibody reaction as de-
scribed in Materials and Methods. (B) Effects of mAb BM165 on
adhesion of normal human keratinocytes and on binding of type
VII–NC-1 to laminin 5. Multiwell plates were coated with laminin
5 at 10 mg/ml. After saturation, the wells were incubated with in-
dicated concentrations of mAb BM165 for 60 min before the cell
adhesion experiment (d), or together with soluble type VII–NC-1
(10 mg/ml) for the binding assay (s). Extent of cell adhesion was
measured with a colorimetric reaction at 570 nm. Each point rep-
resents the average of triplicate wells. In the ELISA assay, bound
type VII–NC-1 was determined by a pAb in an enzyme-coupled
second antibody reaction as described in Materials and Methods.
Because the OD values in both systems were in the same range,
the data were presented on a single graph.
Figure 6. Western blot anal-
ysis of the complex of lami-
nin 5 and NC-1 produced in
solution. Laminin 5 alone
(lanes A1 and B1), NC-1
alone (lanes A2 and B2), a
mixture of laminin 5 and NC-1
(lanes A3 and B3), or a mix-
ture of laminin 5 and heat de-
natured NC-1 (lanes A4 and B4) were immunoprecipitated with
anti-a3 mAb (BM-165). The contents of the precipitates were
separated by SDS-PAGE after disulfide bond reduction and vi-
sualized by Western analysis using (A) polyclonal anti-laminin 5
or (B) monoclonal anti-NC-1 (mAb NP-32).The Journal of Cell Biology, Volume 138, 1997 724
blotted by anti-NC-1 (Fig. 8, lane 6) but not by anti-lami-
nin 5 (Fig. 8, lane 2) indicating that the nonbound fraction
contains only NC-1 and is equivalent to the NC-1 used in
the binding studies described above. If complexed laminin
5 and NC-1 are present in the extract, they should be
bound by the anti-b3 column. As seen in Fig. 8, lanes 3 and
4, the materials eluted from the anti-b3 column are West-
ern blotted by both anti-laminin 5 (Fig. 8, lane 3) and anti-
NC-1 (Fig. 8, lane 4) indicating that the bound fraction
contains both NC-1 and laminin 5.
In previous studies, Keene et al. (1987) showed that the
anchoring fibrils in the papillary dermis of skin terminated
in junctions, the anchoring plaques. These plaques showed
the inclusion of type IV collagen by ultrastructural immu-
nolocalization. Studies conducted at the same time, but
not included in the publication, showed the absence of an-
choring plaque labeling with mAbs to laminin a1, but mi-
nor labeling with polyclonal anti-laminin antibodies. At
that time we were unsure how to interpret the result. We
have repeated the immunolocalization of laminin 5 in skin
with particular attention to the anchoring plaques. As
shown in Fig. 9, A–D, the plaques are clearly recognized
by anti-a3 antibodies. Further, in double-labeling experi-
ments, the reactivity of monoclonal anti-a3 is colocalized
to the plaques with the reactivity of polyclonal anti-NC-1
(Fig. 9, E and F).
Discussion
The data presented here suggest that at least two mecha-
nisms promote epithelial–stromal attachment. The first is
the previously suggested (Champliaud et al., 1996) binding
Figure 7. Visualization of the
laminin 5–NC-1 complex
formed in solution by trans-
mission electron microscopy
after rotary shadowing. Col-
lagen VII–NC-1, laminin 5,
and a mixture of both mole-
cules were dialyzed against
0.2 M ammonium bicarbon-
ate, diluted 1:1 with glycerol,
and rotary shadowed. (Lm5)
The images visualized are
characteristic of laminin 5
molecules. The 107-nm mole-
cules appear as extended
rods with globular knobs at
each terminus. (NC1) Under
the conditions used to main-
tain the stability of the com-
plex, NC-1 appears as an
asymmetrical spheroid, z41
nm in narrowest diameter.
Due to incomplete digestion,
helical domains of type VII
collagen can be seen on some
NC-1 molecules. (Complex)
Images of the laminin 5–type
VII collagen–NC-1 complex
preparation contains uncom-
plexed laminin 5 and NC-1,
and images that appear as a
complex of one laminin 5
molecule with one NC-1 mol-
ecule, in which the long arm
may correspond to laminin 5
and the big globular domain
to NC-1.
Figure 8. Western blot anal-
ysis of the laminin 5–type VII
collagen–NC-1 complex im-
munoaffinity purified from
collagenase extracts of amni-
otic membranes. Type VII
collagen–NC-1 was first af-
finity purified on mAb NP-32
from collagenase extracts of
amniotic membranes. Eluted
fractions of NC-1 were
pooled, dialyzed against
PBS, and passed over a mAb
6F12 affinity chromatography column. Bound materials were im-
munoblotted with polyclonal anti-laminin 5 (pLm5; lane 3), and
anti-NC-1 (mAb NP-32, lane 4). The bound material shows the
pattern obtained for purified laminin 5 (lane 1), which does not
contain NC-1 (lane 2) and for purified NC-1 (not shown, but
identical to lane 6). The nonbound fraction contains NC-1 only
(lane 6) but no laminin 5 (lane 2).Rousselle et al. Laminin 5 Binds Collagen Type VII 725
of the laminin 5–6/7 complex to lamina densa components
of the epithelial basement membrane. That model sug-
gests that the presence of g1 chains in laminin 6 or 7 pro-
vides a nidogen binding site, and the VI domains of both
b1/b2 and g1 allow for assembly of the complex with the
laminin 1 network. The model also suggests that null phe-
notypes resulting from mutations in laminin a3 would re-
sult in significant destabilization of epithelial–stromal ad-
hesion, as these mutations would be null for laminin 5, 6,
and 7. However, the model also predicts that mutations in
b3 or g2 would only affect the presence of laminin 5, and
not either laminin 6 or 7. Therefore, since both laminins 6
and 7 contain an a3 chain and promote adhesion of kerati-
nocytes, laminin 6 or 7 should at least partially substitute
for the absence of laminin 5. This prediction is incorrect,
as mutations in genes encoding a3, b3, or g2 all result in
Herlitz’s junctional epidermolysis bullosa. Therefore, a
second and equally (or more) important mechanism by
which laminin 5 interacts with a basement membrane or
stromal component must exist.
The present study indicates a second mechanism involv-
ing the binding of monomeric laminin 5 to type VII col-
lagen NC-1 domain. These findings suggest a model (Fig.
10) that predicts that monomeric laminin 5 is the primary
bridge between hemidesmosomal a6b4 and type VII col-
lagen, and the laminin 5–6/7 complex is present within the
interhemidesmosomal spaces. This model is consistent
with the following observations: (a) Monomeric laminin 5
binds integrin a6b4 (Niessen et al., 1994) and type VII col-
lagen strongly, but has minimal affinity for other basement
membrane components; (b) approximately half of the ex-
tractable laminin 5 is complexed with laminins 6 and 7
(Champliaud et al., 1996); (c) the laminin 5–6/7 complex
binds collagen IV strongly through nidogen (Mayer et al.,
1995); (d) laminin 5 is uniformly distributed along the epi-
thelial basement membrane (Rousselle et al., 1991), while
anchoring fibrils (Ellison and Garrod, 1984) and type VII
collagen (Sakai et al., 1986) are concentrated under
hemidesmosomes. This model is also consistent with (e)
the ultrastructure of the anchoring complex and the spatial
orientation of the involved molecules (Ellison and Garrod,
1984); and (f) with the phenotypes of null mutations in
BPAG2 (McGrath et al., 1995; Jonkman et al., 1995), inte-
grin b4 (Vidal et al., 1995; Dowling et al., 1996; van der
Neut et al., 1996) or a6 (Georges-Labouesse et al., 1996),
laminin 5 chains, and type VII collagen (Uitto et al., 1994;
Bruckner-Tuderman, 1994), as the absence of laminin 5
results in the lethal Herlitz’s form of epidermolysis
bullosa. The absence of type VII collagen results in severe
generalized dystrophic epidermolysis bullosa, and the lack
of  a6b4 integrin causes lethal blistering in the mouse
(Dowling et al., 1996; van der Neut et al., 1996; Georges-
Labouesse et al., 1996) although the absence of integrin
a6b4 in humans appears to be less severe (Vidal et al.,
1995). Absent mouse BPAG1 (Guo et al., 1995), BPAG2
(McGrath et al., 1995, 1996), or plectin (Gache et al., 1996;
Figure 9. Localization of
laminin 5 to anchoring
plaques. Laminin 5 is local-
ized to anchoring plaques in
human skin using mAb
BM165 and 5-nm (A, arrow)
or 1 nm silver-enhanced col-
loidal gold (B–D). Labeling
of the lamina lucida and an-
choring plaques is intense us-
ing silver-enhanced 1 nm col-
loidal gold in comparison to
5 nm colloidal gold. Using a
mixture of mAb BM165
(anti-laminin  a3) and pAb
3959 (anti-type VII collagen
NC-1), laminin 5 is seen to
colocalize with type VII col-
lagen in anchoring plaques
(E, 1-nm silver-enhanced
particles specific for mAb
BM165 [small arrow] and 10-
nm silver-enhanced particles
are specific for pAb 3959
[large arrow]; F, 5-nm parti-
cles specific for mAb BM165
(small arrow) and 15-nm par-
ticles specific for pAb 3959
[large arrow]. Bar, 100 nm.The Journal of Cell Biology, Volume 138, 1997 726
McLean et al., 1996; Smith et al., 1996) results in relatively
mild blistering, suggesting that their roles in epidermal ad-
hesion can be partially compensated by other hemidesmo-
somal components.
The precise role of laminin 5–6/7 complex–nidogen
binding is now less clear. As the presence of laminins 6 or
7 cannot substitute for laminin 5 in stabilizing epithelial at-
tachment to the basement membrane, the characteristics
of monomeric laminin 5 best fit its direct role in the an-
choring complex. Since monomeric laminin 5 has no
known mechanism for binding to components of the lam-
ina densa other than to type VII collagen, it is difficult to
imagine how it might function outside the hemidesmo-
some, given our current level of understanding. It is likely
that the laminin 5 detected within the basement mem-
brane between hemidesmosomes is the laminin 5–6/7 com-
plex. Within this interhemidesmosomal space it is capable
of associations with the basolateral plasma membrane
through integrin a3b1 (Delwel et al., 1994; DiPersio et al.,
1995). Its presence there may stabilize the association of
the basement membrane with the basolateral keratinocyte
surface. The laminin 5–6/7 complex may play additional
important roles in basement membrane assembly and sta-
bility.
We have previously shown that NC-1 can bind collagen
IV and, to a considerably lesser extent, laminin 1 (Burge-
son et al., 1990). As shown in Fig. 3 B, in this assay the rel-
ative binding of NC-1 to the laminin 1–nidogen complex is
minimal, the binding to type IV collagen is moderate, and
NC-1 binds laminin 5 most strongly. The failure of NC-1 to
bind laminin 6 was informative. As laminin 5 and laminin 6
share the a3 chain, this observation suggests that either b3
or g2 mediate the interaction with type VII collagen. Bind-
ing to b3 or g2 could occur within the a-helical long arm
domains I/II, or within the short arms. In this regard, the
measurements of conformational stability of the NC-1
binding domain are informative. NC-1 binding is lost if
laminin 5 is subjected to temperatures above 658C. As this
is well below the midpoint transition temperature for de-
naturation of the coiled-coil long arm (728C) (Rousselle et
al., 1995), the data suggest that binding of laminin 5 to NC-1
occurs within the b3 or g2 short arms. Of interest, recently
a case of junctional epidermolysis bullosa has been de-
scribed that is due to a homozygous inframe exon skip re-
sulting in the deletion of part of domains III and VI of the
g2 chain (Pulkkinen et al., 1994a). The processing cleavage
site is retained within domain III, but lies only six residues
from the deletion, and therefore the authors speculate that
the phenotype may result from failure of g2 chain process-
ing. If only processed g2 interacts with NC-1, this would be
consistent with the observed phenotype. The laminin 5
used in this present study consists of a mixture of mole-
cules containing both full-length, unprocessed g2 (155 kD),
and processed 105 kD g2. Therefore, we are unable to de-
termine if g2 processing influences NC-1 binding.
The rotary-shadowed images of the NC-1–laminin 5
complex are consistent with the proposed interaction of
NC-1 with an end of laminin 5, but not with the coiled-coil
domain. We were unable to unambiguously identify the
globule at the extended end of laminin 5 within the com-
plex as the a3G domain since the monomeric laminin 5 in
the preparation is very heterogeneous at one end, consis-
tent with the electrophoretic pattern indicating the presence
of a mixture of processing intermediates, and consistent
with the observed heterogeneity being at the NH2-termi-
nus. However, our impression is that the globule seen at
the free end of laminin 5 in the complex is less heteroge-
neous than seen for the NH2 terminus of monomeric lami-
nin 5, and is therefore likely to be the G domain. It is inter-
esting that under the lower glycerol concentrations used in
the spreading buffer NC-1 appears as a spheroid rather
than in an extended trident shape as we have previously
reported (Lunstrum et al., 1986). It is possible that the ob-
served globular structure is due to noncovalent intrachain
interactions of the von Willebrand factor domains (Fretto
et al., 1986). The lower glycerol concentrations were
needed to visualize the complex, suggesting either that
glycerol at high concentration destabilizes the complex, or
that spreading of the short arms disrupts the complex. It is
also surprising that all the complexes visualized appeared
to be between a single molecule of trimeric NC-1, and a
single laminin 5 molecule. Since NC-1 is a homotrimer, we
expected that up to three laminin 5 molecules might be
bound by each NC-1 domain.
These studies do not directly address the subdomain(s)
within NC-1 to which laminin 5 binds. However, type XII
and XIV collagens were selected as candidates for the
solid-phase binding studies since they share both fibronec-
tin type III repeats and von Willebrand factor A repeats
with NC-1. Therefore, since laminin 5 does not bind either
of these collagens, the subdomain responsible for binding
must contain sequences that are unique to type VII col-
lagen.
If laminin 5 binds type VII collagen NC-1 domains with
high affinity, then laminin 5 could mediate the interaction
of anchoring fibrils and would be expected within anchor-
ing plaques. Previous attempts to localize laminin to the
anchoring plaques with monoclonal anti-a1 or polyclonal
anti-laminin 1 were ambiguous. The present study shows
Figure 10. Model for the presence of monomeric laminin 5 and
complexed laminin 5 within an epithelial–stromal junction. The
cartoon depicts monomeric laminin 5 as the bridge between
hemidesmosomal integrin a6b4 and the type VII collagen NC-1
domain. The tight binding of laminin 5 to a6b4 and to type VII
collagen provides the primary resistance to frictional forces. The
laminin 5–6/7 complex is shown within the basement membrane
between hemidesmosomes, bound by integrin a3b1 where it po-
tentially functions to maintain basement membrane stability and
contact with the epithelial basolateral surface. Rousselle et al. Laminin 5 Binds Collagen Type VII 727
the localization of anti-a3 reactivity to the anchoring
plaques, colocalized with anti-type VII collagen NC-1.
This strongly suggests that the tight binding of NC-1 and
laminin 5 seen in vitro is physiologically significant.
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